Vendors

Latest Issue of OR Manager
August 2019

Editorial

Our series on artificial intelligence (AI) concludes in this issue with part 2 of an in-depth look at legal and ethical questions (cover story) as well as advice for evaluating new AI products (“Consider all angles when choosing AI technology,” p 13). But insights about future trends like AI do…

Read More

By: Elizabeth Wood
July 24, 2019
Share

Are you prepared for the OR of the Future?

Innovative technology and surgical procedures, including artificial intelligence, will be explored in depth during the OR Manager Conference, September 18-20 in New Orleans. The new OR of the Future gives attendees a unique opportunity to learn through interactive experiences, educational sessions, and discussions with leading experts: product manufacturers as well…

Read More

By: Cynthia Saver, MS, RN
July 24, 2019
Share

Disruptive innovation in supply chain: Impact of Amazon Business and technology, Part 2

Supply chain is ripe for innovation, as Amazon Business and technology manufacturers have discovered. In part 1 of this two-part series, we focused on the company’s role in the supply chain (OR Manager, February 2019, 1, 9-12). In part 2, we look at technology-related trends and innovations that can improve…

Read More

By: Cynthia Saver, MS, RN
February 20, 2019
Share

Disruptive innovation in supply chain: Impact of Amazon Business and technology, Part 1

Supply chain is the lifeblood of the OR, so any disruption in the flow of that lifeblood can lead to outcomes ranging from dissatisfaction with backorders to chaos if a new implant doesn’t arrive on time. But disruption also can be a positive force, especially if it supports flow. When…

Read More

By: Cynthia Saver, MS, RN
January 14, 2019
Share

Comprehensive ROI pitch helps to procure OR equipment

Multiple requests for new equipment and technology—usually from surgeons but also sometimes from staff—are not uncommon. As part of their due diligence, OR leaders must determine whether the return on investment (ROI) justifies the purchase. Doing ROI calculations systematically—and involving key stakeholders—can help ensure that the organization makes the best…

Read More

By: Cynthia Saver, MS, RN
January 14, 2019
Share

Surgical VAC mines new software for deeper look at products

After transitioning from a paper-based data and operations management system to one that uses relational database software, Lahey Hospital and Medical Center (LHMC) in Burlington, Massachusetts, saved more than $1 million in product purchases in 2017. The surgical value analysis committee (VAC) evaluated 150 product requests and managed the conversion…

Read More

By: Robert Dolan, MD,, Kristen Murphy, MBA, and Edward Aiello
January 14, 2019
Share

ECRI Institute announces new white paper on top value analysis challenges

Editor's Note ECRI Institute on October 30 announced a new white paper--Value Analysis: Addressing Top Challenges by Using the PICOTS Framework--which presents findings from national seminars on the top five challenges value analysis professionals face daily. The challenges are: Antiquated workflow C-suite buy-in Accessibility to data Physician engagement Bandwidth. The…

Read More

By: Judy Mathias
October 31, 2018
Share

US House votes to kill medical device tax

Editor's Note A bill that would repeal the medical device tax cleared the House of Representatives on July 24 in a 283-132 vote. the July 24 The Hill reports. The tax provided part of the funding for the Affordable Care Act. Rep Erik Paulsen (R-Minn), the bill sponsor, says the…

Read More

By: Judy Mathias
July 26, 2018
Share

Study: Medical device tax hurts investment in R&D

Editor's Note: This study from Iowa State University shows companies have cut funding for research and development (R&D) in response to the medical device tax imposed by the Affordable Care Act. Since 2013, the 2.3% excise tax has significantly reduced: R&D investment by $34 million Sales revenue by $188 million…

Read More

By: Judy Mathias
June 6, 2018
Share

FDA delays UDI compliance dates for class I, unclassified devices

Editor's Note The Food and Drug Administration (FDA) on January 12 announced a delay in enforcement of unique device identification (UDI) requirements for class I and unclassified devices until September 24, 2020. The FDA also will not enforce direct mark requirements for these devices until September 24, 2022. The guidance…

Read More

By: Judy Mathias
January 16, 2018
Share
OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat